Abstract
Recent research interest has focused on the role of vaccination in preventing type 1 diabetes in high-risk patients. High-risk subjects are identified on the basis of genetic and antibody markers. While no single intervention strategy has been demonstrated to have universal efficacy, this review focuses on the developments and recent patents in this field.
Keywords: Type 1 diabetes, LADA, GADA, vaccination, immunotherapy
Related Journals
Current Diabetes Reviews
Current Medicinal Chemistry
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Related Books
The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response
Natural Immunomodulators: Promising Therapy for Disease Management
Herbal Immunity Boosters Against COVID-19
The Role of Nitric Oxide in Type 2 Diabetes
Mitochondrial DNA and the Immuno-inflammatory Response: New Frontiers to Control Specific Microbial Diseases
Pharmacological and Molecular Perspectives on Diabetes
Diabesity: A Multidisciplinary Approach
Frontiers in Clinical Drug Research – Anti Allergy Agents
Frontiers in Clinical Drug Research-Diabetes and Obesity
Frontiers in Inflammation
16